ESSITY A

Essity plans to spin off or sell its €2.5‑€3bn Consumer Tissue unit, sparking a market debate on value and portfolio focus in Sweden’s industrial sector.

Essity beats earnings expectations, gains investor confidence, and sees a 12% stake added by Industrivärden—boosting Stockholm’s OMXS30 and the hygiene sector.

Essity’s $2.7 bn acquisition of Kenvue’s Brazilian feminine‑care division boosts its Latin America presence with popular Carefree, Sempre Livre and o.b. brands, aiming for growth, cost savings and ESG alignment.

Essity’s cash‑only purchase of Kenvue’s Brazilian feminine‑care brands offers strong margins, e‑commerce growth, and sustainability gains—yet it faces regulatory, currency, and supply‑chain risks that could impact returns.

Essity’s new “sell” rating underscores shrinking margins, rising commodity costs and a competitive gap in sustainability. Discover the key risks, opportunities, and why investors should watch the next earnings call closely.

Stockholm market sees mixed earnings, with defence and logistics firms topping forecasts while hygiene products face cost pressures and investor scrutiny.

Essity AB strengthens governance with new Chief Legal Officer Andreas Mattsson, boosting compliance, ESG readiness, and risk‑managed growth for global expansion.

Stockholm stocks dip as tech falls; Essity, Tele2 & Telia gain on defensive staples, showing resilience amid rising costs & inflation.

OMXSPI dips 1.5% as commodity prices fall and Fed tightening worries grow, but defensive sectors like healthcare and hygiene goods rise, while mining suffers.

Swedish OMX S30 shows muted moves amid geopolitical risks, with Essity’s sustainable push and SEB’s rating lift sparking sector‑specific gains.